Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lane, M. Collins, V. Bigley, C. Morgan, J. Lordan (Newcastle-upon-Tyne, United Kingdom). Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant?. Eur Respir J 2012; 40: Suppl. 56, 2452

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation Source: Eur Respir J, 51 (5) 1701960; 10.1183/13993003.01960-2017 Year: 2018 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Pulmonary function and respiratory complications in hematopoietic cell transplant Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Treatment of a novel disease with whole lung lavages and stem cell transplantation Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Bronchiolar and pulmonary complications in recipients of bone marrow/stem cell transplantation Source: Annual Congress 2010 - The lung in haematological disorders Year: 2010 Pulmonary function changes following allogeneic haematopoietic cell transplantation Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Lung transplantation for pulmonary fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated? Source: Eur Respir J 2005; 25: 402-405 Year: 2005 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Lung transplantation for diffuse bronchiectasis Source: Annual Congress 2012 - Update on bronchiectasis Year: 2012 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007